MCP-1 levels varied significantly between the 8 treatment groups (p<0.0001; Figure 7F), with sepsis inciting increases in CS, CS-IT, CS-Ab and CS-NS treated pups compared to naïve or sham animals (N vs. CS, p=0.0011; N vs. CS-IT, p=0.0048; N vs. CS-Ab, p=0.0216; N vs. CS-NS, p=0.0399; Sh vs. CS, p=0.0009; Sh vs. CS-IT, p=0.0039; Sh vs. CS-Ab, p = 0.0176; Sh vs. CS-NS, p=0.0338). This evidence concerns the gene CCL2 and Sepsis.